Otter Creek Advisors LLC Has $341,000 Stock Position in Avantor, Inc. (NYSE:AVTR)

Otter Creek Advisors LLC cut its position in Avantor, Inc. (NYSE:AVTR) by 92.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,163 shares of the company’s stock after selling 196,935 shares during the period. Otter Creek Advisors LLC’s holdings in Avantor were worth $341,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in shares of Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after buying an additional 8,206,695 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after purchasing an additional 5,354,678 shares during the period. FMR LLC raised its stake in shares of Avantor by 557.2% during the third quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after buying an additional 3,963,912 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in Avantor by 18.2% in the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after buying an additional 2,719,615 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in Avantor by 146.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock worth $67,996,000 after acquiring an additional 1,562,018 shares during the period. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Shares of AVTR stock opened at $17.22 on Thursday. The company has a fifty day moving average price of $20.69 and a two-hundred day moving average price of $22.79. Avantor, Inc. has a one year low of $17.14 and a one year high of $28.00. The stock has a market cap of $11.73 billion, a P/E ratio of 16.56, a P/E/G ratio of 1.55 and a beta of 1.28. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the previous year, the company earned $0.22 earnings per share. As a group, equities analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on AVTR shares. Morgan Stanley decreased their price objective on Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Stifel Nicolaus decreased their target price on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Monday, February 10th. Barclays dropped their target price on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Raymond James restated an “outperform” rating and set a $24.00 price objective (down from $26.00) on shares of Avantor in a report on Monday, February 10th. Finally, UBS Group reaffirmed a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Avantor has an average rating of “Moderate Buy” and an average price target of $25.92.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.